Efficiency Comparative Approach of Plant-Produced Monoclonal Antibodies against Rabies Virus Infection

Efficiency Comparative Approach of Plant-Produced Monoclonal Antibodies against Rabies Virus Infection

Rabies encephalitis is a fatal zoonotic viral disease caused by the neurotropic rabies virus. It remains a major public health concern as it causes almost 100% fatality and has no effective medication after the onset of the disease. However, this illness is preventable with the timely administration...

Full description

Bibliographic Details
Main Authors:	Boonlert Lumlertdacha, Bancha Mahong, Kaewta Rattanapisit, Christine Joy I. Bulaon, Thiravat Hemachudha, Waranyoo Phoolcharoen
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Series:	Vaccines
Subjects:	rabies virus post-exposure prophylaxis monoclonal antibody <i>Nicotiana benthamiana</i> plant produced antibody cocktail
Online Access:	https://www.mdpi.com/2076-393X/11/8/1377

Similar Items

Production of monoclonal antibodies against botulinum neurotoxin in Nicotiana benthamiana
by: Kornchanok Sangprasat, et al.
Published: (2024-12-01)

Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro
by: Balamurugan Shanmugaraj, et al.
Published: (2020-11-01)

Advances in the progress of monoclonal antibodies for rabies
by: Linlin Fan, et al.
Published: (2022-01-01)

Antitumor effect of plant-produced anti-CTLA-4 monoclonal antibody in a murine model of colon cancer
by: Christine Joy I. Bulaon, et al.
Published: (2023-08-01)

Expression and Functional Evaluation of Recombinant Anti-receptor Activator of Nuclear Factor Kappa-B Ligand Monoclonal Antibody Produced in Nicotiana benthamiana
by: Wanuttha Boonyayothin, et al.
Published: (2021-06-01)

Reproducibility and flexibility of monoclonal antibody production with Nicotiana benthamiana
by: Kelsi Swope, et al.
Published: (2022-12-01)

In Vivo Efficacy of SYN023, an Anti-Rabies Monoclonal Antibody Cocktail, in Post-Exposure Prophylaxis Animal Models
by: Tzu-Yuan Chao, et al.
Published: (2020-02-01)

Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis
by: Paola De Benedictis, et al.
Published: (2016-04-01)

Defining the volume of rabies immunoglobulins/ rabies monoclonal antibodies requirement for wound infiltration of category III animal exposures – an exploratory study
by: Ravish S. Haradanhalli, et al.
Published: (2021-12-01)

Comparing recombinant human rabies monoclonal antibody (ormutivimab) with human rabies immunoglobulin (HRIG) for postexposure prophylaxis: A phase III, randomized, double-blind, non-inferiority trial
by: Xiaoqiang Liu, et al.
Published: (2023-09-01)

Immunological Detection of Rabies Virus in Brain Tissues of Infected Dogs by Monoclonal Antibodies
by: Nyoman Mantik Astawa, et al.
Published: (2010-12-01)

Population Pharmacodynamic Analyses of Human Anti-Rabies Virus Monoclonal Antibody (Ormutivimab) in Healthy Adult Subjects
by: Junnan Zhang, et al.
Published: (2022-07-01)

Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposureResearch in context
by: Gagandeep Kang, et al.
Published: (2023-07-01)

Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli, expressed as secretory IgA1 and IgA2 in plants
by: Audrey Y-H Teh, et al.
Published: (2021-01-01)

Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2
by: Konlavat Siriwattananon, et al.
Published: (2021-01-01)

Development of Monoclonal Antibodies for Detection of Conserved and Variable Epitopes of Large Protein of Rabies Virus
by: Wen Zhao, et al.
Published: (2021-01-01)

Production and N-glycan engineering of Varlilumab in Nicotiana benthamiana
by: Kim Dua Nguyen, et al.
Published: (2023-08-01)

Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application
by: Wanuttha Boonyayothin, et al.
Published: (2022-06-01)

An oligosaccharyltransferase from Leishmania donovani increases the N-glycan occupancy on plant-produced IgG1
by: Gernot Beihammer, et al.
Published: (2023-08-01)

Generation of Monoclonal Antibodies against Variable Epitopes of the M Protein of Rabies Virus
by: Jie Liu, et al.
Published: (2019-04-01)

Neutralizing activity of anti-respiratory syncytial virus monoclonal antibody produced in Nicotiana benthamiana
by: Nuttapat Pisuttinusart, et al.
Published: (2024-12-01)

Feasibility of plant-expression system for production of recombinant anti-human IgE: An alternative production platform for therapeutic monoclonal antibodies
by: Oranicha Hanittinan, et al.
Published: (2022-12-01)

A fast and easy one-step purification strategy for plant-made antibodies using Protein A magnetic beads
by: Loïc Faye, et al.
Published: (2024-01-01)

In Vivo Efficacy of a Cocktail of Human Monoclonal Antibodies (CL184) Against Diverse North American Bat Rabies Virus Variants
by: Richard Franka, et al.
Published: (2017-09-01)

A combination of two human monoclonal antibodies cures symptomatic rabies
by: Guilherme Dias de Melo, et al.
Published: (2020-11-01)

Preparation and use of monoclonal antibodies to detect Phytophthora nicotianae var. nicotianae
by: Blanka Pekárová-Kyněrová, et al.
Published: (1999-06-01)

Production and characterization of a human antisperm monoclonal antibody against CD52g for topical contraception in women
by: Gabriela Baldeon-Vaca, et al.
Published: (2021-07-01)

Antiviral mechanisms of two broad-spectrum monoclonal antibodies for rabies prophylaxis and therapy
by: Maira Zorzan, et al.
Published: (2023-08-01)

Antigenic variations of recent street rabies virus
by: Wenbo Wang, et al.
Published: (2019-01-01)

Monoclonal Antibodies for Pre- and Postexposure Prophylaxis of COVID-19: Review of the Literature
by: Serena Vita, et al.
Published: (2022-08-01)

Implications of O-glycan modifications in the hinge region of a plant-produced SARS-CoV-2-IgA antibody on functionality
by: Pia Uetz, et al.
Published: (2024-03-01)

Codon optimization regulates IgG3 and IgM expression and glycosylation in N. benthamiana
by: Lin Sun, et al.
Published: (2023-12-01)

Safety and neutralizing rabies antibody in healthy subjects given a single dose of rabies immune globulin caprylate/chromatography purified
by: Hanna K, et al.
Published: (2018-06-01)

Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production
by: Balamurugan Shanmugaraj, et al.
Published: (2020-07-01)

Pharmacokinetic study and preliminary evaluation of safety and efficacy of the recombinant human monoclonal antibodies against rabies virus (rhRIG) in Chinese healthy population: A randomized, single-blinded, placebo-controlled phase Ia clinical trial
by: Xi Chen, et al.
Published: (2023-09-01)

5’ and 3’ untranslated regions strongly enhance performance of geminiviral replicons in Nicotiana benthamiana leaves
by: Andrew G. Diamos, et al.
Published: (2016-02-01)

Rabies virus monitoring in bat populations in Rondônia state, Brazil
by: Marilene Fernandes de Almeida, et al.

A New Workflow to Generate Monoclonal Antibodies against Microorganisms
by: Markus Göthel, et al.
Published: (2021-10-01)

Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates
by: Konlavat Siriwattananon, et al.
Published: (2021-05-01)

A novel ELISA for quantification of glycoprotein in human rabies vaccines using a clinically proven virus neutralizing human monoclonal antibody
by: Sunil Gairola, et al.
Published: (2020-08-01)